Despite the fact that our findings revealed a framework in which the ARHGEF2/EDN1 pathway contributes to ER stress-related drug resistance in HCC by promoting angiogenesis, several questions remain. The gene discussed is ARHGEF2; the disease is hepatocellular carcinoma.